Tirzepatide 15mg Summary Description: Tirzepatide is a novel, dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist designed for the treatment of type 2 diabetes and obesity
David jones pharmacy sell online , its classed as a food supplement so shouldnt require a script
This distinguishes it from better-known compounds such as semaglutide (Ozempic/Wegovy), which targets only the GLP-1 receptor, and from tirzepatide (Mounjaro/Zepbound), which is a dual GLP-1/GIP agonist
Inhibition of new fat formation: Acts preventively by blocking the lipogenesis process
Gentle swirling, not vigorous shaking, is key
The combination of reduced insulin levels and increased fat oxidation creates conditions favorable for hepatic ketogenesis